## IONQ: IonQ, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -6.3% below STRENGTH zone (3.0-6.0%); PEG 2.71 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-8.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.44)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bearish (Bullish: 0, Bearish: 0)

**1. IonQ Stock (NYSE: IONQ) Update: Why Shares Slid to $46 and What to Watch When Markets Reopen**
- Source: ts2.tech | 20251228T100919 | Neutral | Relevance: 100%
- IonQ (NYSE: IONQ) stock experienced a significant 7.7% drop to $46.00 during a holiday trading week characterized by thin liquidity, sparking debate among investors about the nature of the selloff. This decline occurred despite recent positive news, including a significant deal to deliver a 100-qubit system to South Korea. Investors are now weighing IonQ's fundamentals, analyst forecasts, and high short interest, ahead of the market reopening.

**2. IonQ stock today: IONQ slips after hours as South Korea 100‑qubit deal hits tape**
- Source: ts2.tech | 20251230T000837 | Somewhat-Bearish | Relevance: 100%
- IonQ shares slipped 1.6% in after-hours trading after announcing a deal to deliver a 100-qubit Tempo system to South Korea's KISTI, which will be integrated with KISTI’s flagship supercomputing cluster. This agreement is significant for investors looking for clearer milestones in quantum commercialization, as on-premises system deliveries offer more tangible progress than cloud-only access. Although financial terms were not disclosed, this collaboration aims to create South Korea’s first onsite "hybrid quantum-classical" integration for researchers, universities, and enterprises.

**3. Carnegie Investment Counsel Sells 155,878 Shares of IonQ, Inc. $IONQ**
- Source: MarketBeat | 20251228T060919 | Neutral | Relevance: 100%
- Carnegie Investment Counsel reduced its stake in IonQ, Inc. by 36.7% in the 3rd quarter, selling 155,878 shares and holding 268,704 shares valued at $16.53 million. Despite a significant EPS miss, IonQ's revenue grew 221.5% year-over-year to $39.87 million, exceeding estimates. Institutional investors like Vanguard, Norges Bank, and Amazon have substantial positions, while insiders have recently sold shares.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.11M) |
| Sells | 6 ($7.34M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 8.3% (+18.5%)
- Morgan Stanley: 7.4% (+29.9%)
- Blackrock Inc.: 6.3% (+23.2%)
- Geode Capital Manage: 1.9% (+24.0%)
- State Street Corpora: 1.8% (+19.9%)

### Key Risks

1. High beta (2.62) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_10 falling (-8.6% 5d) with bearish MACD, trend may be turning.
3. Insider selling cluster: $7.3M in recent transactions.
4. High short interest (20.2%, 3.5 days to cover): squeeze risk or crowded bearish bet.
5. Near-term weakness: 12.6% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.71 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (8.7x). Revenue growth strong at 82% YoY. Insider selling cluster ($7.3M in 90 days), potential headwind. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.1B |
| Beta | 2.62 |
| 52W Range | $17.88 - $84.64 |
| Short Interest | 20.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.71 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from 2.3% to -6.3% (-8.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.3pp (needs >3.0% for momentum thesis). Underperforming sector by 6.5pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.02x) but short-term weakness (below SMA20). RSI neutral at 43. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -6.34% (CS: 2) | Weak |
| RSI_14 | 42.8 | Neutral |
| MACD Histogram | -0.24 | Bearish |
| vs SMA20 | 0.912x | Below |
| vs SMA50 | 0.874x | Below |
| vs SMA200 | 1.020x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $45.34
- **Stop Loss:** $37.44 (17.4% risk)
- **Target:** $53.24 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 139
- **Position Value:** $6,302.26
- **Portfolio %:** 6.30%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-25 (Est: $-0.48)

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*